Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now includes expanded Locations with new site entries across Alabama, Connecticut, Florida, Minnesota, Missouri, Ohio, Virginia, New South Wales, South Australia, and Victoria. The HHS Vulnerability Disclosure link was removed and the revision is updated to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T20:56:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Publications section wording updated to say publications are automatically filled from PubMed, and revision labels changed from v3.2.0 to v3.3.2. These are minor text and version updates to the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:24:02.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removal of the broad government funding lapse notice from the page; this change does not affect the study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T06:49:08.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The two screenshots depict the same study details page with no substantive differences in core content, such as the study overview, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T20:40:55.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T05:07:57.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Update to version v3.1.0; removal of several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and archival of v3.0.2.
    Difference
    0.4%
    Check dated 2025-09-29T02:57:32.000Z thumbnail image

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.